{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:26:17Z","timestamp":1781216777575,"version":"3.54.1"},"reference-count":79,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SUM Katowice","award":["KNW-1-103\/N\/8\/0"],"award-info":[{"award-number":["KNW-1-103\/N\/8\/0"]}]},{"name":"SUM Katowice","award":["KNW-1- 100\/K\/9\/0"],"award-info":[{"award-number":["KNW-1- 100\/K\/9\/0"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background and Aims: Experimental models using carbon tetrachloride (CCl4) and D-galactosamine (D-GalN) can be used in preclinical assessment of acute liver failure (ALF) therapies. Unfortunately, these models are characterized by different dynamics of liver injury depending on the animal strain, administered hepatotoxin, and its dose. The aim of this study was to compare known rat and mouse models of ALF with a view to their future introduction into preclinical cell therapy experiments. In particular, based on histopathological and molecular changes, we suggested experimental time cut-off points for an effective stem cell therapeutic intervention. Methods: ALF was induced by a single intraperitoneal injection of CCl4 in mice (50 \u03bcL\/100 g b.w.) and rats (200 \u03bcL\/100 g b.w.) and D-GalN in mice (150 mg\/100 g b.w.) and rats (50 mg\/100 g b.w.). Blood and liver samples were collected 12 h, 24 h, 48 h and 7 days after intoxication. Blood morphology, liver function blood tests, histopathological changes, proliferation activity, apoptosis, fibrosis, and gene expression were analysed to assess liver damage. Results: At 12 h, 24 h, and 48 h after CCl4 injection, mouse livers showed moderate inflammatory infiltration and massive pericentral necrosis. In rats treated with CCl4, minor lymphocytic infiltration in the liver parenchyma was seen at 12 h, followed by necrosis that appeared around central veins at 24 h and persisted to 48 h. In D-GalN-injected mice, the first histopathological signs of liver injury appeared at 48 h. In the livers of D-GalN-treated rats, moderate pericentral inflammatory infiltration occurred after 12 h, 24 h, and 48 h, accompanied by increased proliferation and apoptosis. All histological changes were accompanied by decreasing expression of certain genes. In most experimental groups of rats and mice, both histological and molecular parameters returned to the baseline values between 48 h and 7 days after intoxication. Conclusions: In mice and rats with CCl4-induced ALF, signs of liver failure can be seen as early as 12 h and develop to 48 h. In the D-GalN-induced model, mice are more resistant to the hepatotoxic effect than rats (after 12 h), and the early hepatitis phase can be observed much later, after 48 h. These cut-off points seem to be optimal for suppressing inflammation and applying effective stem cell therapy for acute liver injury.<\/jats:p>","DOI":"10.31083\/j.fbl2708237","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T01:46:34Z","timestamp":1660268794000},"source":"Crossref","is-referenced-by-count":8,"title":["Dynamics of Acute Liver Injury in Experimental Models of Hepatotoxicity in the Context of Their Implementation in Preclinical Studies on Stem Cell Therapy"],"prefix":"10.31083","volume":"27","author":[{"given":"Piotr","family":"Czekaj","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Kr\u00f3l","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Liman\u00f3wka","sequence":"first","affiliation":[{"name":"Students Scientific Society, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Skubis-Sikora","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Kolanko","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Bogunia","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Hermyt","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Michalik","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Sikora","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Prusek","sequence":"first","affiliation":[{"name":"Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniela","family":"Grajoszek","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Paj\u0105k","sequence":"first","affiliation":[{"name":"Department of Pathomorphology and Molecular Diagnostic, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Mathai S, Panackel C, Thomas R, Sebastian B. Recent advances in management of acute liver failure. Indian Journal of Critical Care Medicine. 2015; 19: 27\u201333.","DOI":"10.4103\/0972-5229.148636"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fontana RJ. Acute Liver Failure Including Acetaminophen Overdose. Medical Clinics of North America. 2008; 92: 761\u2013794.","DOI":"10.1016\/j.mcna.2008.03.005"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology. 2017; 66: 1047\u20131081.","DOI":"10.1016\/j.jhep.2016.12.003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gotthardt D, Riediger C, Weiss KH, Encke J, Schemmer P, Schmidt J, et al. Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrology, Dialysis, Transplantation. 2007; 22: viii5\u2013viii8.","DOI":"10.1093\/ndt\/gfm650"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Castaldo ET, Chari RS. Liver transplantation for acute hepatic failure. HPB. 2006; 8: 29\u201334.","DOI":"10.1080\/13651820500465741"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mendizabal M. Liver transplantation in acute liver failure: a challenging scenario. World Journal of Gastroenterology. 2016; 22: 1523\u20131531.","DOI":"10.3748\/wjg.v22.i4.1523"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kantola T, Ilmakunnas M, Koivusalo A, Isoniemi H. Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland. Scandinavian Journal of Surgery. 2011; 100: 8\u201313.","DOI":"10.1177\/145749691110000103"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Michalik M, G\u0142ady\u015b A, Czekaj P. Differentiation of Cells Isolated from Afterbirth Tissues into Hepatocyte-Like Cells and their Potential Clinical Application in Liver Regeneration. Stem Cell Reviews and Reports. 2021; 17: 581\u2013603.","DOI":"10.1007\/s12015-020-10045-2"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lim R, Malhotra A, Tan J, Chan ST, Lau S, Zhu D, et al. First-in-Human Administration of Allogeneic Amnion Cells in Premature Infants with Bronchopulmonary Dysplasia: a Safety Study. Stem Cells Translational Medicine. 2018; 7: 628\u2013635.","DOI":"10.1002\/sctm.18-0079"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Melville JM, McDonald CA, Bischof RJ, Polglase GR, Lim R, Wallace EM, et al. Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs. PLoS ONE. 2017; 12: e0173572.","DOI":"10.1371\/journal.pone.0173572"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kolanko E, Grajoszek A, Czekaj P. Immunosuppressive Potential of Activated Human Amniotic Cells in an Experimental Murine Model of Skin Allo- and Xenotransplantation. Frontiers in Medicine. 2021; 8: 715590.","DOI":"10.3389\/fmed.2021.715590"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang C, Sheng Q, Bai H, Ding Y, Dou X. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World Journal of Gastroenterology. 2017; 23: 7978\u20137988.","DOI":"10.3748\/wjg.v23.i45.7978"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Ramanathan R, Rupert S, Selvaraj S, Satyanesan J, Vennila R, Rajagopal S. Role of Human Wharton\u2019s Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d -Galactosamine Induced Acute Liver Injury in Mice. Journal of Clinical and Experimental Hepatology. 2017; 7: 205\u2013214.","DOI":"10.1016\/j.jceh.2017.03.010"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Liu Q, Liu Q, Li J, Wei L, Ren K, Zhang X, et al. Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure. Stem Cell Research & Therapy. 2018; 9: 321.","DOI":"10.1186\/s13287-018-1063-2"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Nagamoto Y, Takayama K, Ohashi K, Okamoto R, Sakurai F, Tachibana M, et al. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. Journal of Hepatology. 2016; 64: 1068\u20131075.","DOI":"10.1016\/j.jhep.2016.01.004"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Baumgartner D, LaPlante-O\u2019Neill PM, Sutherland DE, Najarian JS. Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. European Surgical Research. 1983; 15: 129\u2013135.","DOI":"10.1159\/000128344"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Lin N, Wu H, Ho JH, Liu C, Lee OK. Mesenchymal stem cells prolong survival and prevent lethal complications in a porcine model of fulminant liver failure. Xenotransplantation. 2019; 26: e12542.","DOI":"10.1111\/xen.12542"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Zhang Y, Cai W, Huang Q, Gu Y, Shi Y, Huang J, et al. Mesenchymal stem cells alleviate bacteria\u2010induced liver injury in mice by inducing regulatory dendritic cells. Hepatology. 2014; 59: 671\u2013682.","DOI":"10.1002\/hep.26670"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Zhang Q, Huang Y, Sun J, Gu T, Shao X, Lai D. Immunomodulatory effect of human amniotic epithelial cells on restoration of ovarian function in mice with autoimmune ovarian disease. Acta Biochimica et Biophysica Sinica. 2019; 51: 845\u2013855.","DOI":"10.1093\/abbs\/gmz065"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Lim R, Hodge A, Moore G, Wallace EM, Sievert W. A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis. Frontiers in Pharmacology. 2017; 8: 549.","DOI":"10.3389\/fphar.2017.00549"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine. 2016; 14: 45.","DOI":"10.1186\/s12967-016-0792-1"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Anger F, Camara M, Ellinger E, Germer C, Schlegel N, Otto C, et al. Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Liver Regeneration after Ischemia Reperfusion Injury in Mice. Stem Cells and Development. 2019; 28: 1451\u20131462.","DOI":"10.1089\/scd.2019.0085"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Czekaj P, Kr\u00f3l M, Liman\u00f3wka \u0141, Michalik M, Lorek K, Gramignoli R. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy. European Journal of Pharmacology. 2019; 861: 172597.","DOI":"10.1016\/j.ejphar.2019.172597"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"McGill MR, Jaeschke H. Animal models of drug-induced liver injury. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease. 2019; 1865: 1031\u20131039.","DOI":"10.1016\/j.bbadis.2018.08.037"},{"key":"ref25","unstructured":"Fahmy SR, Hamdi SAH, Abdel-Salam HA. Curative effect of dietary freshwater and marine crustacean extracts on carbon tetrachloride-induced nephrotoxicity. Australian Journal of Basic and Applied Sciences. 2009; 3: 2118\u20132129."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Apte U. Models to Study Liver Regeneration. Liver regeneration: basic mechanisms, relevant models and clinical applications (pp. 15\u201340). Elsevier\/Academic Press: Kansas City, United States. 2015.","DOI":"10.1016\/B978-0-12-420128-6.00002-6"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biology. 2018; 17: 274\u2013283.","DOI":"10.1016\/j.redox.2018.04.019"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicologic Pathology. 1996; 24: 181\u2013189.","DOI":"10.1177\/019262339602400206"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Bizzaro D, Crescenzi M, Di Liddo R, Arcidiacono D, Cappon A, Bertalot T, et al. Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. Clinical Science. 2018; 132: 255\u2013272.","DOI":"10.1042\/CS20171260"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Ustuner D, Colak E, Dincer M, Tekin N, Burukoglu Donmez D, Akyuz F, et al. Posttreatment Effects of Olea Europaea L. Leaf Extract on Carbon Tetrachloride-Induced Liver Injury and Oxidative Stress in Rats. Journal of Medicinal Food. 2018; 21: 899\u2013904.","DOI":"10.1089\/jmf.2017.0143"},{"key":"ref31","unstructured":"Zarezade V, Moludi J, Mostafazadeh M, Mohammadi M, Veisi A. Antioxidant and hepatoprotective effects of Artemisia dracunculus against CCl4-induced hepatotoxicity in rats. Avicenna Journal of Phytomedicine. 2018; 8: 51\u201362."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Reviews of Physiology Biochemistry and Pharmacology. 1974; 77\u2013106.","DOI":"10.1007\/BFb0027661"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Galun E, Zeira E, Pappo O, Peters M, Rose-John S. Liver regeneration induced by a designer human IL\u20106\/sIL\u20106R fusion protein reverses severe hepatocellular injury. The FASEB Journal. 2000; 14: 1979\u20131987.","DOI":"10.1096\/fj.99-0913com"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Babu PR, Bhuvaneswar C, Sandeep G, Ramaiah CV, Rajendra W. Hepatoprotective role of Ricinus communis leaf extract against D-galactosamine induced acute hepatitis in albino rats. Biomedicine & Pharmacotherapy. 2017; 88: 658\u2013666.","DOI":"10.1016\/j.biopha.2017.01.073"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Zhang Y. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World Journal of Gastroenterology. 2016; 22: 2558\u20132565.","DOI":"10.3748\/wjg.v22.i8.2558"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Drucker C, Rabe B, Chalaris A, Schulz E, Scheller J, Rose-John S. Interleukin-6 trans-signaling regulates glycogen consumption after D-galactosamine-induced liver damage. Journal of Interferon and Cytokine Research. 2009; 29: 711\u2013718.","DOI":"10.1089\/jir.2008.0095"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Lu Y, Wang WJ, Song YZ, Liang ZQ. The protective mechanism of schisandrin A in d-galactosamine-induced acute liver injury through activation of autophagy. Pharmaceutical Biology. 2014; 52: 1302\u20131307.","DOI":"10.3109\/13880209.2014.890232"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Tsutsui S, Hirasawa K, Takeda M, Itagaki S, Kawamura S, Maeda K, et al. Apoptosis of Murine Hepatocytes Induced by High Doses of Galactosamine. Journal of Veterinary Medical Science. 1997; 59: 785\u2013790.","DOI":"10.1292\/jvms.59.785"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Catal T, Bolkent S. Combination of Selenium and Three Naturally Occurring Antioxidants Administration Protects d-Galactosamine-Induced Liver Injury in Rats. Biological Trace Element Research. 2008; 122: 127\u2013136.","DOI":"10.1007\/s12011-007-8061-z"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Janakat S, Al-Merie H. Optimization of the dose and route of injection, and characterisation of the time course of carbon tetrachloride-induced hepatotoxicity in the rat. Journal of Pharmacological and Toxicological Methods. 2002; 48: 41\u201344.","DOI":"10.1016\/S1056-8719(03)00019-4"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Bing\u00fcl \u0130, Ayd\u0131n AF, Ba\u015faran-K\u00fc\u00e7\u00fckgergin C, Do\u011fan-Ekici I, \u00c7oban J, Do\u011fru-Abbaso\u011flu S, et al. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats. International Immunopharmacology. 2016; 39: 199\u2013207.","DOI":"10.1016\/j.intimp.2016.07.028"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012; 9: 676\u2013682.","DOI":"10.1038\/nmeth.2019"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006; 55: 569\u2013578.","DOI":"10.1136\/gut.2005.084475"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Krishna M. Histological Grading and Staging of Chronic Hepatitis. Clinical Liver Disease. 2021; 17: 222\u2013226.","DOI":"10.1002\/cld.1014"},{"key":"ref45","unstructured":"Rich L, Whittaker P. Collagen and picosirius red staining: A poalrized light assessment of fibrillar hue and spatioal distribution. Journal of Morphology. 2005; 22: 97\u2013104."},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for Valid Histopathologic Scoring in Research. Veterinary Pathology. 2013; 50: 1007\u20131015.","DOI":"10.1177\/0300985813485099"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, et al. C-Met Confers Protection against Chronic Liver Tissue Damage and Fibrosis Progression after Bile Duct Ligation in Mice. Gastroenterology. 2009; 137: 297\u2013308.e3084.","DOI":"10.1053\/j.gastro.2009.01.068"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Bai Q, Yan H, Sheng Y, Jin Y, Shi L, Ji L, et al. Long-term acetaminophen treatment induced liver fibrosis in mice and the involvement of Egr-1. Toxicology. 2017; 382: 47\u201358.","DOI":"10.1016\/j.tox.2017.03.008"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC. Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia. 2000; 43: 763\u2013772.","DOI":"10.1007\/s001250051374"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Sutti S, Rigamonti C, Vidali M, Albano E. CYP2E1 autoantibodies in liver diseases. Redox Biology. 2014; 3: 72\u201378.","DOI":"10.1016\/j.redox.2014.11.004"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Montagner A, Polizzi A, Fouch\u00e9 E, Ducheix S, Lippi Y, Lasserre F, et al. Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut. 2016; 65: 1202\u20131214.","DOI":"10.1136\/gutjnl-2015-310798"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Hong L, Sun Q, Xu T, Wu Y, Zhang H, Fu R, et al. New role and molecular mechanism of Gadd45a in hepatic \ufb01brosis. World Journal of Gastroenterology. 2016; 22: 2779.","DOI":"10.3748\/wjg.v22.i9.2779"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhai H, Wan Y, Wang X, Chen H, Dong L, et al. Recombinant Human HPS Protects Mice and Nonhuman Primates from Acute Liver Injury. International Journal of Molecular Sciences. 2021; 22: 12886.","DOI":"10.3390\/ijms222312886"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Knockaert L, Berson A, Ribault C, Prost P, Fautrel A, Pajaud J, et al. Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver. Laboratory Investigation. 2012; 92: 396\u2013410.","DOI":"10.1038\/labinvest.2011.193"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Tierney DJ, Haas AL, Koop DR. Degradation of cytochrome P450 2E1: Selective loss after labilization of the enzyme. Archives of Biochemistry and Biophysics. 1992; 293: 9\u201316.","DOI":"10.1016\/0003-9861(92)90358-4"},{"key":"ref56","unstructured":"Dai Y, Cederbaum AI. Inactivation and degradation of human cytochrome P4502E1 by CCl4 in a transfected HepG2 cell line. Journal of Pharmacology and Experimental Therapeutics. 1995; 275: 1614\u20131622."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Aristatile B, Al-Assaf AH, Pugalendi KV. Carvacrol ameliorates the PPAR-A and cytochrome P450 expression on D-galactosamine induced hepatotoxicity rats. African Journal of Traditional, Complementary and Alternative Medicines. 2014; 11: 118\u2013123.","DOI":"10.4314\/ajtcam.v11i3.18"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Eslam M, Khattab MA, Harrison SA. Peroxisome proliferator-activated receptors and hepatitis C virus. Therapeutic Advances in Gastroenterology. 2011; 4: 419\u2013431.","DOI":"10.1177\/1756283X11405251"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Wang H, Rao B, Lou J, Li J, Liu Z, Li A, et al. The Function of the HGF\/c-Met Axis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 2020; 8: 55.","DOI":"10.3389\/fcell.2020.00055"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Otsuka T, Takagi H, Horiguchi N, Toyoda M, Sato K, Takayama H, et al. CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression. FEBS Letters. 2002; 532: 391\u2013395.","DOI":"10.1016\/S0014-5793(02)03714-6"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Nakayama N, Kashiwazaki H, Kobayashi N, Hamada J, Ogiso Y, Itakura Y, et al. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma. Hepatology. 1996; 24: 596\u2013602.","DOI":"10.1002\/hep.510240323"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver International. 2004; 24: 335\u2013344.","DOI":"10.1111\/j.1478-3231.2004.0926.x"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: Clinical implications. Hepatology. 1995; 21: 106\u2013112.","DOI":"10.1002\/hep.1840210119"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Drucker C, Gewiese J, Malchow S, Scheller J, Rose-John S. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. Journal of Autoimmunity. 2010; 34: 29\u201337.","DOI":"10.1016\/j.jaut.2009.08.003"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Tsuji T, Shinohara T. Pathological study of chronic d-galactosamine induced hepatitis in mice by administration of adjuvants an animal model of the chronic active hepatitis. Gastroenterologia Japonica. 1981; 16: 9\u201320.","DOI":"10.1007\/BF02820419"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Chung H, Kim H, Jang K, Kim M, Yang J, Kang K, et al. Comprehensive analysis of differential gene expression profiles on d-galactosamine-induced acute mouse liver injury and regeneration. Toxicology. 2006; 227: 136\u2013144.","DOI":"10.1016\/j.tox.2006.07.026"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Asaoka Y, Sakai H, Takahashi N, Hirata A, Tsukamoto T, Yamamoto M, et al. Intraperitoneal injection ofd-galactosamine provides a potent cell proliferation stimulus for the detection of initiation activities of chemicals in rat liver. Journal of Applied Toxicology. 2005; 25: 554\u2013561.","DOI":"10.1002\/jat.1095"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Zhang Y, Miao H, Yan H, Sheng Y, Ji L. Hepatoprotective effect of Forsythiae Fructus water extract against carbon tetrachloride-induced liver fibrosis in mice. Journal of Ethnopharmacology. 2018; 218: 27\u201334.","DOI":"10.1016\/j.jep.2018.02.033"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Jiang W, Tan Y, Cai M, Zhao T, Mao F, Zhang X, et al. Human Umbilical Cord MSC-Derived Exosomes Suppress the Development of CCl4-Induced Liver Injury through Antioxidant Effect. Stem Cells International. 2018; 2018: 6079642.","DOI":"10.1155\/2018\/6079642"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods in Molecular Medicine. 2005; 117: 237\u2013250.","DOI":"10.1385\/1-59259-940-0:237"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G, et al. Hepatocytes Express Nerve Growth Factor during Liver Injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. The American Journal of Pathology. 2003; 163: 1849\u20131858.","DOI":"10.1016\/S0002-9440(10)63544-4"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Yukawa H, Noguchi H, Oishi K, Takagi S, Hamaguchi M, Hamajima N, et al. Cell Transplantation of Adipose Tissue-Derived Stem Cells in Combination with Heparin Attenuated Acute Liver Failure in Mice. Cell Transplantation. 2009; 18: 611\u2013618.","DOI":"10.1177\/096368970901805-617"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Ren X, Xin L, Zhang M, Zhao Q, Yue S, Chen K, et al. Hepatoprotective effects of a traditional Chinese medicine formula against carbon tetrachloride-induced hepatotoxicity in vivo and in vitro. Biomedicine & Pharmacotherapy. 2019; 117: 109190.","DOI":"10.1016\/j.biopha.2019.109190"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Gruttadauria S, Grosso G, Pagano D, Biondi A, Echeverri GJ, Seria E, et al. Marrow-Derived Mesenchymal Stem Cells Restore Biochemical Markers of Acute Liver Injury in Experimental Model. Transplantation Proceedings. 2013; 45: 480\u2013486.","DOI":"10.1016\/j.transproceed.2012.06.087"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Putra A, Rosdiana I, Darlan DM, Alif I, Hayuningtyas F, Wijaya I, et al. Intravenous Administration is the Best Route of Mesenchymal Stem Cells Migration in Improving Liver Function Enzyme of Acute Liver Failure. Folia Medica. 2020; 62: 52\u201358.","DOI":"10.3897\/folmed..e47712"},{"key":"ref76","unstructured":"Varaa N, Azandeh S, Khorsandi L, Bijan Nejad D, Bayati V, Bahreini A. Ameliorating effect of encapsulated hepatocyte-like cells derived from umbilical cord in high mannuronic alginate scaffolds on acute liver failure in rats. Iranian Journal of Basic Medical Sciences. 2018; 21: 928\u2013935."},{"key":"ref77","unstructured":"Li D, Fan J, He X, Zhang X, Zhang Z, Zeng Z, et al. Therapeutic effect comparison of hepatocyte-like cells and bone marrow mesenchymal stem cells in acute liver failure of rats. International Journal of Experimental Pathology. 2015; 8: 11\u201324."},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Wang J, Ren H, Yuan X, Ma H, Shi X, Ding Y. Interleukin\u201010 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis. Hepatology Research. 2018; 48: E194\u2013E202.","DOI":"10.1111\/hepr.12969"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Lam SP, Luk JM, Man K, Ng KT, Cheung CK, Rose-John S, et al. Activation of interleukin-6-induced glycoprotein 130\/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Liver Transplantation. 2010; 16: 1195\u20131206.","DOI":"10.1002\/lt.22136"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/8\/10.31083\/j.fbl2708237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:17:13Z","timestamp":1732709833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/8\/10.31083\/j.fbl2708237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2768-6701(22)00603-7"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2708237","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"237"}}